THThe Hindu·2hHealth
score-0.30
FDA Completes GMP Inspection of Gland Pharma Hyderabad Facility, Issuing Four Observations
Original
U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad
“Reports regulatory observations in a factual tone, emphasizing compliance issues without alarming language or catastrophic framing.”